We are analyzing https://link.springer.com/article/10.1007/s12094-023-03116-6.

Title:
ALKBH5 decreases SLC7A11 expression by erasing m6A modification and promotes the ferroptosis of colorectal cancer cells | Clinical and Translational Oncology
Description:
Background Colorectal cancer (CRC) is the major subtype of gastrointestinal malignancy and involves cancer-related genes and signaling pathways to regulate ferroptosis. The present study was conducted to analyze the role of alkB homolog 5 (ALKBH5) in the ferroptosis of CRC cells and provide novel targets for CRC treatment. Methods The transcriptional and protein levels of ALKBH5 and solute carrier family 7 members 11 (SLC7A11) in tissues and cells were determined by qRT-PCR and Western blot assay. HCT116 and SW620 cells were transfected with ALKBH5 overexpression vectors to determine cell viability and levels of reactive oxygen species (ROS), Fe+, glutathione, and glutathione peroxidase 4 using cell counting kit-8, colony formation, fluorescence probe, assay kits, and Western blot assay. The N6-methyladenosine (m6A) level and the enrichment of m6A on SLC7A11 mRNA were measured by m6A quantitative analysis and m6A methylated RNA immunoprecipitation-qPCR, and the mRNA stability was determined after actinomycin D treatment. CRC cells were treated with the combination of SLC7A11 and ALKBH5 overexpression vectors to confirm the mechanism. Nude mice were subcutaneously injected with CRC cells overexpressing ALKBH5. Results ALKBH5 was downregulated in CRC and ALKBH5 overexpression promoted ROS release and ferroptosis. ALKBH5 erased the m6A modification on SLC7A11 mRNA to reduce the mRNA stability of SLC7A11, further reducing SLC7A11 expression. SLC7A11 overexpression reversed the promotive role of ALKBH5 overexpression in ferroptosis. ALKBH5 upregulation mitigated tumor growth in vivo. Conclusions ALKBH5 reduced SLC7A11 transcription by erasing m6A modification, thus promoting the ferroptosis of CRC cells.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Science
Education
Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,016 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We see no obvious way the site makes money.

While profit motivates many websites, others exist to inspire, entertain, or provide valuable resources. Websites have a variety of goals. And this might be one of them. Link.springer.com could be secretly minting cash, but we can't detect the process.

Keywords {🔍}

pubmed, cancer, article, google, scholar, alkbh, cas, ferroptosis, central, colorectal, slca, cell, liu, cells, wang, modification, crc, rna, demethylase, zhang, data, research, mrna, access, clin, huang, yang, role, oncol, progression, res, privacy, cookies, content, expression, overexpression, mol, transl, jiang, authors, springer, analysis, information, publish, search, oncology, promotes, manuscript, glutathione, nmethyladenosine,

Topics {✒️}

large-scale clip-seq data perk-nrf2-ho-1 signaling pathway month download article/chapter real-time quantitative pcr involves cancer-related genes tiam1-nrf2/ho-1 axis posttranscriptionally activating nfe2l2/nrf2 foxo3/mir-21/spry2 axis m6a-ythdf2-dependent manner cystine transporter slc7a11/xct protein-rna interaction networks alkbh5 rna demethylase rna demethylase alkbh5 a-igf2bp2-dependent manner regulating bmi1-mediated activation slc7a11-dependent inhibition translational oncology aims m6a demethylase alkbh5 full article pdf related subjects cell counting kit-8 colorectal cancer cells privacy choices/manage cookies reducing slc7a11 expression ampk/mtor pathway m6a rna methylation alkbh5 overexpression vectors erasing m6a modification m6a methylation modification pkmyt1 m6a modification reactive oxygen species tao ye hk2 mrna mediated epithelial ovarian cancer cell death dis determine cell viability m6a quantitative analysis holds exclusive rights cancer cell int mol cell biochem article clinical slc7a11 overexpression reversed n6-methyladenosine article luo bo hu european economic area check access nucleic acids res database issue curr protoc pharmacol

Schema {🗺️}

WebPage:
      mainEntity:
         headline:ALKBH5 decreases SLC7A11 expression by erasing m6A modification and promotes the ferroptosis of colorectal cancer cells
         description: Colorectal cancer (CRC) is the major subtype of gastrointestinal malignancy and involves cancer-related genes and signaling pathways to regulate ferroptosis. The present study was conducted to analyze the role of alkB homolog 5 (ALKBH5) in the ferroptosis of CRC cells and provide novel targets for CRC treatment. The transcriptional and protein levels of ALKBH5 and solute carrier family 7 members 11 (SLC7A11) in tissues and cells were determined by qRT-PCR and Western blot assay. HCT116 and SW620 cells were transfected with ALKBH5 overexpression vectors to determine cell viability and levels of reactive oxygen species (ROS), Fe+, glutathione, and glutathione peroxidase 4 using cell counting kit-8, colony formation, fluorescence probe, assay kits, and Western blot assay. The N6-methyladenosine (m6A) level and the enrichment of m6A on SLC7A11 mRNA were measured by m6A quantitative analysis and m6A methylated RNA immunoprecipitation-qPCR, and the mRNA stability was determined after actinomycin D treatment. CRC cells were treated with the combination of SLC7A11 and ALKBH5 overexpression vectors to confirm the mechanism. Nude mice were subcutaneously injected with CRC cells overexpressing ALKBH5. ALKBH5 was downregulated in CRC and ALKBH5 overexpression promoted ROS release and ferroptosis. ALKBH5 erased the m6A modification on SLC7A11 mRNA to reduce the mRNA stability of SLC7A11, further reducing SLC7A11 expression. SLC7A11 overexpression reversed the promotive role of ALKBH5 overexpression in ferroptosis. ALKBH5 upregulation mitigated tumor growth in vivo. ALKBH5 reduced SLC7A11 transcription by erasing m6A modification, thus promoting the ferroptosis of CRC cells.
         datePublished:2023-02-23T00:00:00Z
         dateModified:2023-02-23T00:00:00Z
         pageStart:2265
         pageEnd:2276
         sameAs:https://doi.org/10.1007/s12094-023-03116-6
         keywords:
            Colorectal cancer
            Ferroptosis
             ALKBH5
             SLC7A11
            m6A modification
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12094-023-03116-6/MediaObjects/12094_2023_3116_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12094-023-03116-6/MediaObjects/12094_2023_3116_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12094-023-03116-6/MediaObjects/12094_2023_3116_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12094-023-03116-6/MediaObjects/12094_2023_3116_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12094-023-03116-6/MediaObjects/12094_2023_3116_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12094-023-03116-6/MediaObjects/12094_2023_3116_Fig6_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12094-023-03116-6/MediaObjects/12094_2023_3116_Fig7_HTML.png
         isPartOf:
            name:Clinical and Translational Oncology
            issn:
               1699-3055
            volumeNumber:25
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer International Publishing
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Jing Luo
               affiliation:
                     name:Minhang Branch, Zhongshan Hospital, Fudan University
                     address:
                        name:Department of Oncology, Minhang Branch, Zhongshan Hospital, Fudan University, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hongmei Yu
               affiliation:
                     name:Minhang Branch, Zhongshan Hospital, Fudan University
                     address:
                        name:Department of Oncology, Minhang Branch, Zhongshan Hospital, Fudan University, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Zhen Yuan
               affiliation:
                     name:Minhang Branch, Zhongshan Hospital, Fudan University
                     address:
                        name:Department of Oncology, Minhang Branch, Zhongshan Hospital, Fudan University, Shanghai, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Tao Ye
               url:http://orcid.org/0000-0001-5429-5076
               affiliation:
                     name:Minhang Branch, Zhongshan Hospital, Fudan University
                     address:
                        name:Department of Oncology, Minhang Branch, Zhongshan Hospital, Fudan University, Shanghai, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Bo Hu
               affiliation:
                     name:Minhang Branch, Zhongshan Hospital, Fudan University
                     address:
                        name:Department of Oncology, Minhang Branch, Zhongshan Hospital, Fudan University, Shanghai, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:ALKBH5 decreases SLC7A11 expression by erasing m6A modification and promotes the ferroptosis of colorectal cancer cells
      description: Colorectal cancer (CRC) is the major subtype of gastrointestinal malignancy and involves cancer-related genes and signaling pathways to regulate ferroptosis. The present study was conducted to analyze the role of alkB homolog 5 (ALKBH5) in the ferroptosis of CRC cells and provide novel targets for CRC treatment. The transcriptional and protein levels of ALKBH5 and solute carrier family 7 members 11 (SLC7A11) in tissues and cells were determined by qRT-PCR and Western blot assay. HCT116 and SW620 cells were transfected with ALKBH5 overexpression vectors to determine cell viability and levels of reactive oxygen species (ROS), Fe+, glutathione, and glutathione peroxidase 4 using cell counting kit-8, colony formation, fluorescence probe, assay kits, and Western blot assay. The N6-methyladenosine (m6A) level and the enrichment of m6A on SLC7A11 mRNA were measured by m6A quantitative analysis and m6A methylated RNA immunoprecipitation-qPCR, and the mRNA stability was determined after actinomycin D treatment. CRC cells were treated with the combination of SLC7A11 and ALKBH5 overexpression vectors to confirm the mechanism. Nude mice were subcutaneously injected with CRC cells overexpressing ALKBH5. ALKBH5 was downregulated in CRC and ALKBH5 overexpression promoted ROS release and ferroptosis. ALKBH5 erased the m6A modification on SLC7A11 mRNA to reduce the mRNA stability of SLC7A11, further reducing SLC7A11 expression. SLC7A11 overexpression reversed the promotive role of ALKBH5 overexpression in ferroptosis. ALKBH5 upregulation mitigated tumor growth in vivo. ALKBH5 reduced SLC7A11 transcription by erasing m6A modification, thus promoting the ferroptosis of CRC cells.
      datePublished:2023-02-23T00:00:00Z
      dateModified:2023-02-23T00:00:00Z
      pageStart:2265
      pageEnd:2276
      sameAs:https://doi.org/10.1007/s12094-023-03116-6
      keywords:
         Colorectal cancer
         Ferroptosis
          ALKBH5
          SLC7A11
         m6A modification
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12094-023-03116-6/MediaObjects/12094_2023_3116_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12094-023-03116-6/MediaObjects/12094_2023_3116_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12094-023-03116-6/MediaObjects/12094_2023_3116_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12094-023-03116-6/MediaObjects/12094_2023_3116_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12094-023-03116-6/MediaObjects/12094_2023_3116_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12094-023-03116-6/MediaObjects/12094_2023_3116_Fig6_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12094-023-03116-6/MediaObjects/12094_2023_3116_Fig7_HTML.png
      isPartOf:
         name:Clinical and Translational Oncology
         issn:
            1699-3055
         volumeNumber:25
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer International Publishing
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Jing Luo
            affiliation:
                  name:Minhang Branch, Zhongshan Hospital, Fudan University
                  address:
                     name:Department of Oncology, Minhang Branch, Zhongshan Hospital, Fudan University, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hongmei Yu
            affiliation:
                  name:Minhang Branch, Zhongshan Hospital, Fudan University
                  address:
                     name:Department of Oncology, Minhang Branch, Zhongshan Hospital, Fudan University, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Zhen Yuan
            affiliation:
                  name:Minhang Branch, Zhongshan Hospital, Fudan University
                  address:
                     name:Department of Oncology, Minhang Branch, Zhongshan Hospital, Fudan University, Shanghai, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Tao Ye
            url:http://orcid.org/0000-0001-5429-5076
            affiliation:
                  name:Minhang Branch, Zhongshan Hospital, Fudan University
                  address:
                     name:Department of Oncology, Minhang Branch, Zhongshan Hospital, Fudan University, Shanghai, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Bo Hu
            affiliation:
                  name:Minhang Branch, Zhongshan Hospital, Fudan University
                  address:
                     name:Department of Oncology, Minhang Branch, Zhongshan Hospital, Fudan University, Shanghai, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Clinical and Translational Oncology
      issn:
         1699-3055
      volumeNumber:25
Organization:
      name:Springer International Publishing
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Minhang Branch, Zhongshan Hospital, Fudan University
      address:
         name:Department of Oncology, Minhang Branch, Zhongshan Hospital, Fudan University, Shanghai, China
         type:PostalAddress
      name:Minhang Branch, Zhongshan Hospital, Fudan University
      address:
         name:Department of Oncology, Minhang Branch, Zhongshan Hospital, Fudan University, Shanghai, China
         type:PostalAddress
      name:Minhang Branch, Zhongshan Hospital, Fudan University
      address:
         name:Department of Oncology, Minhang Branch, Zhongshan Hospital, Fudan University, Shanghai, China
         type:PostalAddress
      name:Minhang Branch, Zhongshan Hospital, Fudan University
      address:
         name:Department of Oncology, Minhang Branch, Zhongshan Hospital, Fudan University, Shanghai, China
         type:PostalAddress
      name:Minhang Branch, Zhongshan Hospital, Fudan University
      address:
         name:Department of Oncology, Minhang Branch, Zhongshan Hospital, Fudan University, Shanghai, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Jing Luo
      affiliation:
            name:Minhang Branch, Zhongshan Hospital, Fudan University
            address:
               name:Department of Oncology, Minhang Branch, Zhongshan Hospital, Fudan University, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Hongmei Yu
      affiliation:
            name:Minhang Branch, Zhongshan Hospital, Fudan University
            address:
               name:Department of Oncology, Minhang Branch, Zhongshan Hospital, Fudan University, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Zhen Yuan
      affiliation:
            name:Minhang Branch, Zhongshan Hospital, Fudan University
            address:
               name:Department of Oncology, Minhang Branch, Zhongshan Hospital, Fudan University, Shanghai, China
               type:PostalAddress
            type:Organization
      name:Tao Ye
      url:http://orcid.org/0000-0001-5429-5076
      affiliation:
            name:Minhang Branch, Zhongshan Hospital, Fudan University
            address:
               name:Department of Oncology, Minhang Branch, Zhongshan Hospital, Fudan University, Shanghai, China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Bo Hu
      affiliation:
            name:Minhang Branch, Zhongshan Hospital, Fudan University
            address:
               name:Department of Oncology, Minhang Branch, Zhongshan Hospital, Fudan University, Shanghai, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Oncology, Minhang Branch, Zhongshan Hospital, Fudan University, Shanghai, China
      name:Department of Oncology, Minhang Branch, Zhongshan Hospital, Fudan University, Shanghai, China
      name:Department of Oncology, Minhang Branch, Zhongshan Hospital, Fudan University, Shanghai, China
      name:Department of Oncology, Minhang Branch, Zhongshan Hospital, Fudan University, Shanghai, China
      name:Department of Oncology, Minhang Branch, Zhongshan Hospital, Fudan University, Shanghai, China
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(130)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

5.81s.

LINK . SPRINGER . COM {}